New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export NVAX’s income statement to Excel — free account
Novavax, Inc.
NVAXNovavax, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 64.7% from fiscal 2024.
- Revenue
- −3.05%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- +19.3%
Quarter to September 2026, against a year earlier
7.74
0.01
+0.13%
Follow NVAX
Alert me
Where the cash went Twelve months to Sep 30, 2026
Free cash flow was −$243.2M: capital expenditures were more than operating cash flow. Cash fell by $56.3M. What is a cash flow statement?
- Free cash flow
- −$243.2M
- Returned to shareholders
- $6.1M
- Debt, net
- $36.4M borrowed
- Change in cash
- −$56.3M over the period
| Operating cash flow | −238.9 |
|---|---|
| Capital expenditures | −4.3 |
| Free cash flow | −243.2 |
| From investments, net | +100.5 |
| Buybacks, net | −6.1 |
| Debt raised, net | +36.4 |
| Other | +56.2 |
| Change in cash | −56.3 |
Free cash flow
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Operating cash flow | −$245M | −$92M | −$37M | −$239M |
| Capex | −$5.6M | −$5.2M | −$5.3M | −$4.3M |
| Free cash flow | −$250M | −$97M | −$42M | −$243M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Net Income |
+8 more TTM periods Free account |
440.30 | (87.83) | (247.73) | (76.73) |
Depreciation & Amortization |
27.61 | 22.34 | 17.83 | 14.29 | |
Non Cash Items (Other) |
169.40 | 141.31 | 165.93 | 37.24 | |
Accounts Receivable Change |
61.04 | 73.42 | 251.10 | 17.97 | |
Change in inventories |
(3.24) | (5.84) | (2.15) | (8.67) | |
Change in payables and accrued liability |
(322.57) | (170.80) | (145.25) | (145.16) | |
Change in other assets and liabilities |
(622.94) | (69.89) | (69.74) | (69.15) | |
Other operating activities |
22.31 | — | (1.86) | (9.32) | |
Operating Cash Flow |
(244.63) | (91.56) | (36.90) | (238.95) | |
Capital expenditures |
(5.56) | (5.23) | (5.30) | (4.30) | |
Change in intangibles (net) |
(1.86) | — | — | — | |
Short Term Investments Change (Net) |
(91.53) | (86.65) | (162.79) | 100.52 | |
Other investing activities |
— | — | — | 59.40 | |
Investing cash flow |
(78.27) | (33.31) | (109.51) | 154.80 | |
Repayment/Issuance of Debt (Net) |
32.54 | 80.57 | 80.66 | 36.38 | |
Equity Repurchase (Common, Net) |
(4.80) | (8.10) | (5.94) | (6.10) | |
Financing cash flow |
27.74 | 72.47 | 74.71 | 30.27 | |
Exchange Rate Adjustment |
5.93 | 6.84 | (1.24) | (2.42) | |
Change in Cash |
(289.24) | (45.55) | (72.94) | (56.30) | |
Beginning Cash |
545.29 | 256.05 | 256.05 | 256.05 | |
Ending Cash |
256.05 | 210.50 | 183.11 | 199.75 | |
Stock Based Compensation |
36.02 | 33.45 | 32.33 | 31.74 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
(887.71) | (173.12) | 33.96 | (205.01) | |
Investments Change (Net) |
(91.53) | (86.65) | (162.79) | 100.52 | |
Issuance/Purchase of Shares |
(4.80) | (8.10) | (5.94) | (6.10) |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026